NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study
Abstract Aims: The aim of this study was to combine nuclear magnetic resonance-based metabolomics and machine learning to find a glucose-independent molecular signature associated with future type 2 diabetes mellitus development in a subgroup of individuals from the Di@bet.es study. Methods: The study group included 145 individuals developing type 2 diabetes mellitus during the 8-year follow-up, 145 […]
Biosfer Teslab obtains a grant from ICEX Next programme
ICEX Next internationalisation programme The ICEX Next programme aims to promote the internationalisation of Spanish companies and their confidence in foreign markets. The ICEX Internationalization programme, aims to help and internationalize the business, in order to increase turnover abroad, reduce business risk and increase global competitiveness. The programme, aimed at any Spanish SME that has […]
Biosfer Teslab present at the Metabolomics 2022 congress
Biosfer Teslab presents at Metabolomics 2022 The 18th Annual Conference of the Metabolomics Society – Metabolomics 2022 took place in Valencia from 19 to 23 June. The event brought together hundreds of scientists from around the world who presented the latest technological and bioinformatics advances in the field of metabolomics, as well as its application […]
Biosfer Teslab Award for Innovation and Digitalisation Tarragona 2022
Innovation and Digitalisation Award 2022 Tarragona In recognition of the great work carried out by small and medium-sized enterprises as generators of wealth and creators of employment in the performance of their daily work, Banco Santander, Cámara de Comercio de Tarragona and the Cámara de Comercio de Reus, in collaboration with the Cámara de España […]
Diagnostic tool in infant and newborn health
LactApp On 25th, 26th and 27th May the LactApp Medical Congress took place under the slogan “Scientific evidence as a challenge in breastfeeding”. LactApp is a company specialised in breastfeeding support. To this end, they have developed the first App, called LactApp, dedicated to breastfeeding and maternity that solves doubts in a personalised way. With […]
Biosfer Teslab invited in the first Futurecamp Open Future, eHealth & Wellbeing
Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing together with 5 other start-ups in the sector organized by Telefonica Open Future. Last year, Biosfer Teslab was selected to participate in the Tarragona Open Future where it was awarded with the second place. Open […]
Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab
From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine […]
Biosfer Teslab participates in a video of covid-19 research
Last week, in Biosfer Teslab, we participated in the video made as part of the URVGoals project, which shows different research being carried out at the URV with a common goal: to fight against the pandemic. The video shows eight research projects from all fields showing that the fight against covid-19 is totally transversal. In […]
Biosfer Teslab Collaborates in Cancer Studies
Metabolomics can help in the study of different cancers by analysing whether a particular type of tumour is characterised by the development of certain metabolites. To this aim, Biosfer Teslab collaborates directly with Josep Gumà, director of the Oncology Institute of Southern Catalonia, and together with the Higher Technical School of Engineering of the URV […]
Early molecular signature of Parkinson and dementia years before the diseases appear
NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the […]
